WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

DRL’s semaglutide supply hits a stumbling block, affects other companies too

Generic supplies of semaglutide from Dr Reddy’s Laboratories have hit a stumbling block, and this is having a domino effect across other companies, including Torrent Pharmaceuticals and USV

Raccontata daeconomictimes.indiatimes.comthehindubusinessline.comthehindu.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
thehindubusinessline.comStai leggendo11 h fa

DRL’s semaglutide supply hits a stumbling block, affects other companies too

Generic supplies of semaglutide from Dr Reddy’s Laboratories have hit a stumbling block, and this is having a domino effect across other companies, including Torrent Pharmaceuticals and USV

originale
economictimes.indiatimes.com3 h fa

Dr Reddy’s pauses weight loss drug on quality fears

Dr Reddy's Laboratories will halt semaglutide injection supplies until at least October. Unspecified impurities were identified during the active pharmaceutical ingredient manufacturing scale-up. The company assures…

Leggi questa versione → originale
thehindu.com9 h fa

Dr. Reddy’s halts semaglutide supplies on quality concerns, shares plunge, Torrent recalls product

No impact on patient safety or on the product’s existing global regulatory filings

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 9 luglio 2026·economictimes.indiatimes.com

    Dr Reddy's flags quality issue in semaglutide batches, delays commercial supplies

    Dr Reddy's Laboratories has announced a setback in the distribution of their semaglutide products attributed to out-of-specification batches associated with an active ingredient…

  2. giovedì 9 luglio 2026·thehindubusinessline.com

    Dr Reddy's delays semaglutide supply due to active ingredient issue

    Dr. Reddy's delays semaglutide supply due to ingredient issues, impacting shares but posing no safety risks.

  3. giovedì 9 luglio 2026·thehindu.com

    Dr. Reddy’s to delay semaglutide supplies due to quality isssue, shares hit

    Dr. Reddy’s delays semaglutide supplies over quality issues, causing shares to drop amid ongoing investigations and commitment to product safety.

  4. giovedì 9 luglio 2026·thehindu.com

    Dr. Reddy’s to delay semaglutide supplies due to quality issue, shares hit

    Dr. Reddy’s delays semaglutide supplies over quality issues, causing shares to drop amid ongoing investigations and commitment to product safety.

  5. giovedì 9 luglio 2026·economictimes.indiatimes.com

    Dr Reddy's shares slide 7% after delay in semaglutide supplies over quality concerns

    Dr Reddy's shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue involving the active pharmaceutical…

  6. giovedì 9 luglio 2026·thehindubusinessline.com

    Dr Reddy's delays Semaglutide supplies after API-related quality issue

    Dr Reddy's delayed Semaglutide supplies after certain batches failed quality specifications due to an API issue. The company said patient safety is unaffected.

  7. giovedì 9 luglio 2026·thehindubusinessline.com

    DRL’s semaglutide supply hits a stumbling block, affects other companies too

    Generic supplies of semaglutide from Dr Reddy’s Laboratories have hit a stumbling block, and this is having a domino effect across other companies, including Torrent…

  8. giovedì 9 luglio 2026·thehindu.com

    Dr. Reddy’s halts semaglutide supplies on quality concerns, shares plunge, Torrent recalls product

    No impact on patient safety or on the product’s existing global regulatory filings

  9. venerdì 10 luglio 2026·economictimes.indiatimes.com

    Dr Reddy’s pauses weight loss drug on quality fears

    Dr Reddy's Laboratories will halt semaglutide injection supplies until at least October. Unspecified impurities were identified during the active pharmaceutical ingredient…